Alert dwell time: Introduction of a measure to evaluate interruptive clinical decision support alerts

Journal of the American Medical Informatics Association

Volumn 23, Issue e1, 2016, Pages e138-e141

  McDaniel, Robert B ^a   Burlison, Jonathan D ^a   Baker, Donald K ^a   Hasan, Murad ^a   Robertson, Jennifer ^a   Hartford, Christine ^a   Howard, Scott C ^a,b   Sablauer, Andras ^a   Hoffman, James M ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Clinical decision support; Computerized prescriber order entry; Electronic health record; Interruptive alerts; Override rates

Indexed keywords

ACICLOVIR; CYCLOSPORIN; ENALAPRIL; FENTANYL; IBUPROFEN; KETOROLAC; LISINOPRIL; METHOTREXATE; ONDANSETRON; PANTOPRAZOLE; POSACONAZOLE; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; RANITIDINE; SPIRONOLACTONE; TACROLIMUS; VORICONAZOLE;

ALERT DWELL TIME; ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; COMPUTERIZED PROVIDER ORDER ENTRY; ELECTRONIC HEALTH RECORD; HUMAN; ALARM MONITOR; PHYSICIAN ORDER ENTRY SYSTEM; REMINDER SYSTEM; TIME FACTOR;

CLINICAL ALARMS; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; REMINDER SYSTEMS; TIME FACTORS;

EID: 84964940769     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1093/jamia/ocv144     Document Type: Article

References (25)

1. Abookire SA, Teich JM, Sandige H, et al. Improving allergy alerting in a computerized physician order entry system. Proceedings/AMIA Annual Symposium AMIA Symposium 2000:2-6. http://www.ncbi.nlm.nih.gov/ pmc/issues/161274/.
2. Bates DW, Gawande AA. Improving safety with informational technology. N Engl J Med. 2003;348(25):26-34.
3. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems a systematic review. Ann Intern Med. 2012;157(1):29-43.
4. Jaspers MW, Smeulers M, Vermeulen H, et al. Effects of clinical decisionsupport systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. JAMIA 2011;18(3):327-334.
5. Ratwani RM, Gregory Trafton J. A generalized model for predicting postcompletion errors. Top Cogn Sci 2010;2(1):154-167.
6. Carspecken CW, Sharek PJ, Longhurst C, et al. A clinical case of electronic health record drug alert fatigue: consequences for patient outcome. Pediatrics 2013;131(6):e1970-e1973.
7. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. JAMIA. 2006;13(2):138-147.
8. Glassman PA, Simon B, Belperio P, et al. Improving recognition of drug interactions:benefits and barriers to using automated drug alerts. Med Care 2002;40(12):1161-1171.
9. Hsieh TC, Kuperman GJ, Jaggi T, et al. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system. JAMIA 2004;11(6):482-491.
10. Saleem JJ, Patterson ES, Militello L, et al. Exploring barriers and facilitators to the use of computerized clinical reminders. JAMIA 2005;12(4):438-447.
11. Ko Y, Abarca J, Malone DC, et al. Practitioners' views on computerized drug-drug interaction alerts in the VA system. JAMIA 2007;14(1):56-64.
12. van der Sijs H, Aarts J, van Gelder T, et al. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. JAMIA. 2008;15(4):439-448.
13. Jani YH, Barber N, Wong ICK. Characteristics of clinical decision support alert overrides in an electronic prescribing system at a tertiary care paediatric hospital. Int J Pharm Prac Practice 2011;19(5):363-366.
14. Zheng K, Fear K, Chaffee BW, et al. Development and validation of a survey instrument for assessing prescribers' perception of computerized drug-drug interaction alerts. JAMIA 2011;18 (Suppl 1):i51-i61.
15. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002;27(5):377-382.
16. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. JAMIA 2006;13(1):5-11.
17. Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009;169(3):305.
18. Ancker JS, Kern LM, Abramson E, et al. The Triangle Model for evaluating the effect of health information technology on healthcare quality and safety. JAMIA 2011;19(1):62-65.
19. Bryant A, Fletcher G, Payne T. Drug interaction alert override rates in the Meaningful Use era. Appl Clin Inform 2014;5(3):802-813.
20. McCoy AB, Thomas EJ, Krousel-Wood M, et al. Clinical decision support alert appropriateness: a review and proposal for improvement. Ochsner J 2014;14(2):195-202.
21. McCoy AB, Waitman LR, Lewis JB, et al. A framework for evaluating the appropriateness of clinical decision support alerts and responses. JAMIA 2012;19:346-352.
22. Hoffman JM, Baker DK, Howard SC, Laver JH, Shenep JL. Safe and successful implementation of CPOE for chemotherapy at a children's cancer center. J Natl Compr Canc Netw 2011;9(3):36-50.
23. Eligible Professional Meaningful Use Core Measures: Measure 2 of 14. Baltimore, MD: Centers for Medicare and Medicaid Services; 2013.
24. Payne TH, Hines LE, Chan RC, et al. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts. JAMIA 2015:ocv011. http://jamia.oxfordjournals.org/content/20/e1/e2.full.
25. Middleton B, Bloomrosen M, Dente MA, et al. Enhancing patient safety and quality of care by improving the usability of electronic health record systems:recommendations from AMIA. JAMIA 2013;20(e1):e2-e8.